Drug company Zydus Cadila said on Saturday it has received approval from the US health regulator to sell decitabine injection, used to treat certain types of cancer, in the US market. Zydus Cadila said in a statement that the company has received final approval from the US Food and Drug Administration (USFDA) for a 50 mg/vial single-dose vial of decitabine for injection.
Decitabine is used to treat myelodysplastic syndromes, certain types of blood or bone marrow cancer. The drugmaker said the drug would be manufactured at the group’s injectable manufacturing facility.
The Zydus Group now has 326 approvals and has filed over 400 abbreviated new drug applications (ANDAs) since the filing process began in 2003-04.
read all breaking news, breaking news And coronavirus news Here. follow us on Facebook, Twitter And Wire,
,